2026 Interim report
Filed with HKEX · Stock code 2500 · · 97 pages · English
Venus Medtech (Hangzhou), Inc. on 6ix
Earlier from Venus Medtech (Hangzhou)
- Proxy form for use at the egm
- Notice of extraordinary general meeting
- Proposed subscription of new shares and new convertible bonds under specific mandate and (2) notice of extraordinary general meeting
- Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
- Court Sides with Cardiovalve in Edwards patent spat
Later from Venus Medtech (Hangzhou)
- Poll results of the extraordinary general meeting
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Follow Venus Medtech (Hangzhou) into a list and get an email when it puts out news.
Follow Venus Medtech (Hangzhou)